Delany-Moretlwe, S., Lombard, C., Baron, D., Bekker, L., Nkala, B., Ahmed, K., Sebe, M., Brumskine, W., Nchabeleng, M., Palanee-Philips, T., Ntshangase, J., Sibiya, S., Smith, E., Panchia, R., Myer, L., Schwartz, J. L., Marzinke, M., Morris, L., Brown, E. R., Doncel, G. F., Gray, G., & Rees, H. (2018). tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet infectious diseases, 18(11), 1241–1250. http://access.bl.uk/ark:/81055/vdc_100070805307.0x00000d